All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

How many syringe marks 15 mg equals at each concentration, and when it won't fit

Convert 15 mg using the actual mg/mL concentration. See volume and U-100 markings, including amounts that exceed a 1 mL syringe.

By FormBlends Editorial Research|Reviewed by FormBlends Medical Team||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Direct answer: There is no single unit count for 15 mg. For a liquid labeled in mg/mL, divide 15 mg by that concentration to get mL. On a U-100 scale, multiply the mL by 100 to get the corresponding numbered markings. For example, 15 mg at 20 mg/mL is 0.75 mL, corresponding to 75 U-100 markings.

See your GLP-1 options in about 2 minutes. Free and private. See my options →

The complete calculation

Volume in mL = amount in mg ÷ concentration in mg/mL.
U-100 markings = volume in mL × 100. Here “U-100” describes the syringe scale, not a biological potency unit for tirzepatide or another drug. A pen dose counter is a different device and cannot be interpreted using this table.

ConcentrationVolume for 15 mgU-100 markingsFits within a 1 mL syringe?
5 mg/mL3 mL300No
10 mg/mL1.5 mL150No
15 mg/mL1 mL100At its stated capacity
20 mg/mL0.75 mL75Yes
25 mg/mL0.6 mL60Yes
30 mg/mL0.5 mL50Yes

Total contents and concentration are different

A vial labeled “15 mg total” does not give the concentration unless its final liquid volume is also known. If that 15 mg is in 3 mL, the concentration is 5 mg/mL. If it is in 1 mL, the concentration is 15 mg/mL. The same total amount can therefore occupy very different volumes.

Use the pharmacy’s final concentration, including the identity of each active ingredient if the product is a blend. Do not infer a concentration from this article’s examples, a previous vial, or a label that provides only total powder content.

What happens above 100 markings

150 and 300 U-100 markings are volume equivalents, not positions that exist on a 1 mL syringe. The previous article’s two-syringe protocol and pharmacokinetic claims are removed. An amount that exceeds the supplied device’s capacity needs the pharmacy or prescriber to resolve the device or formulation question; the calculation itself does not establish an injection plan.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Dose errors and symptoms

The original page advised contacting the treating provider about a dosing error, persistent vomiting, severe abdominal pain, poor tolerance or a dose concern. That guidance is retained. Its arbitrary “more than 10%” threshold and fixed 12-hour wait were not supported by the reviewed source and are removed. A calculation cannot determine how an individual dosing error should be managed.

FAQ: Questions about this guide

How many U-100 markings is 15 mg?

It depends on concentration: 75 markings at 20 mg/mL, 100 at 15 mg/mL and 150 at 10 mg/mL.

Does 15 mg total on the vial identify the unit count?

No. You also need the final liquid volume or the stated mg/mL concentration.

Can this chart be used for a pen dose counter?

No. This chart converts liquid concentration to volume on a U-100 syringe scale. A branded pen follows its own dose-setting instructions.

Sources checked

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, Ozempic, Wegovy, and Rybelsus are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

15 mg to syringe units: why there is no single number

How many insulin syringe units equal 15 mg of my compounded GLP-1?

  1. No single unit count fits every vial, and this page will not give one. The number depends on how much drug is in each milliliter of your vial. [FDA alert on dosing errors with compounded injectable semaglutide]
  2. FDA received reports of overdoses from compounded semaglutide, some needing hospitalization. In most, patients drew more than prescribed from a multiple-dose vial and took five to 20 times the intended dose. FDA says confusion between milliliters, milligrams and units may have contributed. [FDA alert on dosing errors with compounded injectable semaglutide]
  3. Syringe choice and math both fail in practice. In several FDA reports, patients told to use a U-100 syringe for a small dose drew far more than intended. Health care providers also got the conversion wrong in several reports, which led to five to 10 times the intended dose. [FDA alert on dosing errors with compounded injectable semaglutide]
  4. FDA's dose-error reports name compounded semaglutide, not tirzepatide, so a tirzepatide vial needs its own confirmation. [FDA alert on dosing errors with compounded injectable semaglutide]
  5. FDA lists reported overdose effects as nausea, vomiting, abdominal pain, fainting, headache, dehydration, acute pancreatitis and gallstones. [FDA alert on dosing errors with compounded injectable semaglutide]

Dose-error terms in FAERS reports

These counts cover every FAERS report naming each drug, not only compounded vials, so they cannot tell you how many units your vial needs or whether compounded products cause more errors. They do show that dose and technique mistakes get reported: 'incorrect dose administered' appears in 17.8% of tirzepatide reports and 1.2% of semaglutide reports, while 'wrong technique in device usage process' is 0.34% for semaglutide and 0.04% for tirzepatide.

SemaglutideTirzepatide
Incorrect dose administered
1.19%
17.76%
Incorrect dose administered by device
0.36%
Not in top 500
Overdose
0.27%
0.5%
Accidental overdose
0.18%
1.15%
Wrong technique in device usage process
0.34%
0.04%

Each bar is the share of FDA adverse event reports naming semaglutide and tirzepatide that list that bar's term (incorrect dose administered, incorrect dose administered by device, overdose, accidental overdose or wrong technique in device usage process), not the chance that someone taking it gets that problem.

See the numbers
SemaglutideTirzepatide
Incorrect dose administered1.19%17.76%
Incorrect dose administered by device0.36%Not in top 500
Overdose0.27%0.5%
Accidental overdose0.18%1.15%
Wrong technique in device usage process0.34%0.04%

openFDA FAERS data updated 2026-10-28. Totals: semaglutide 78,023 reports; tirzepatide 181,068 reports. A report means someone linked a symptom to a drug, not that the drug caused it. 'Not in top 500' means the term is not among that drug's 500 most reported terms, so its share is small but unknown.

Source: openFDA drug adverse event endpoint (FAERS), patient.drug.openfda.generic_name and reactionmeddrapt.exact counts (accessed 2026-11-16)

Compare 15 mg with 15 syringe marks

Why are 15 mg and 15 units different amounts?

At the example concentration of 10 mg/mL, 15 mg occupies 1.5 mL and corresponds to 150 U-100 marks. By contrast, 15 marks occupy 0.15 mL and contain 1.5 mg. The identical number does not make the quantities equal.

These are worked arithmetic examples. Change the inputs to compare quantities from a specific label. The table independently holds mass and syringe marks constant so you can see why those comparisons give different results.

Same mass versus same syringe marks, at half, base and double concentration
Concentration (mg/mL)Volume for mass (mL)Marks for massMass at entered marks (mg)
533000.75
101.51501.5
200.75753

Workings: mL = mg ÷ (mg/mL); U-100 marks = mL × 100; mg = (marks ÷ 100) × (mg/mL). The download retains unrounded calculation values.

Scale reference: FDA's U-100 example equates 5 marks with 0.05 mL. FormBlends computes the comparison above from the displayed inputs and equations.

15 mg to U-100 Syringe Marks: Concentration Chart
FormBlends guide cover for 15 mg to U-100 Syringe Marks: Concentration Chart.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-10-02
Page metadata
FormBlends official source
Official source
Mounjaro official website
Official source
Ozempic official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Wegovy official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-10-02.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

15 mg to U-100 Syringe Marks: Concentration Chart research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

GLP-1 Weight Loss

1.7 mg to Units: The Complete Conversion Chart for Compounded GLP-1 Medications

Complete unit conversion for 1.7 mg doses across every compounded concentration, plus the three-question safety check before every injection.

GLP-1 Weight Loss

.25mg to Units: The Complete Conversion Guide for Compounded GLP-1 Medications

How to convert 0.25mg of compounded semaglutide or tirzepatide to units on a U-100 syringe. Full concentration chart plus common conversion errors.

GLP-1 Weight Loss

How Many Units Is 0.5 mg? The Complete Conversion Guide for Compounded GLP-1 Medications

Complete unit conversion for 0.5 mg doses at every compounded semaglutide and tirzepatide concentration, plus how to draw accurately with U-100 syringes.

GLP-1 Weight Loss

How Many mg Is 50 Units? A Complete Conversion Guide for Compounded GLP-1 Medications

50 units equals 5 mg at 10 mg/mL, 2.5 mg at 5 mg/mL, or 10 mg at 20 mg/mL. Complete conversion chart for every compounded semaglutide and tirzepatide dose.

GLP-1 Weight Loss

How Many Units in mg? 60 Checked U-100 Conversion Equivalents

Check 54 mass-to-volume and six 20-unit reverse conversions. Compare concentration, printed readings, barrel capacity and rounding percentages.

GLP-1 Weight Loss

How Many Units Is 2.5 mg? The Complete Conversion Guide for Compounded GLP-1 Medications

Complete unit conversion chart for 2.5 mg doses across all compounded GLP-1 concentrations. Learn to draw accurate doses with U-100 insulin syringes.

GLP-1 Weight Loss

2.4 mg to ml: The Complete Conversion Guide for Compounded GLP-1 Medications

Convert 2.4 mg to ml for compounded semaglutide and tirzepatide at every concentration. Includes syringe charts, error prevention, and dose math.

GLP-1 Weight Loss

30 Units to mg: The Complete Conversion Guide for Compounded GLP-1 Medications

Converting 30 units to mg for compounded semaglutide and tirzepatide depends on vial concentration. Full chart for every common strength plus safety checks.

GLP-1 Weight Loss

33 Units on a U-100 Syringe: What Milligram Dose of Compounded GLP-1 Am I Actually Taking?

33 units on a U-100 syringe equals different milligram doses depending on your vial's concentration. Full conversion chart for every common strength.

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.